Benefits Of 2 Alzheimer’s Treatments Remain Too Small To Justify The Additional Cost To The NHS
National Institute for Health and Care Excellence (NICE) has concluded that the benefits from donanemab (also called Kisunla and made by Eli Lilly) and lecanemab…
Read more...